MAREX GROUP PLC (MRX) Fundamental Analysis & Valuation

NASDAQ:MRX • GB00BMT7GT62

Current stock price

51.52 USD
+0.06 (+0.12%)
At close:
51.6779 USD
+0.16 (+0.31%)
After Hours:

This MRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MRX Profitability Analysis

1.1 Basic Checks

  • MRX had positive earnings in the past year.
  • In the past year MRX had a positive cash flow from operations.
  • In the past 5 years MRX has always been profitable.
  • Each year in the past 5 years MRX had a positive operating cash flow.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • With a Return On Assets value of 0.85%, MRX is not doing good in the industry: 63.75% of the companies in the same industry are doing better.
  • With an excellent Return On Equity value of 23.29%, MRX belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.95%, MRX is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • MRX had an Average Return On Invested Capital over the past 3 years of 1.87%. This is significantly below the industry average of 7.19%.
Industry RankSector Rank
ROA 0.85%
ROE 23.29%
ROIC 0.95%
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)1.87%
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • MRX's Profit Margin of 8.58% is in line compared to the rest of the industry. MRX outperforms 40.42% of its industry peers.
  • MRX's Profit Margin has declined in the last couple of years.
  • MRX has a worse Operating Margin (5.89%) than 70.83% of its industry peers.
  • MRX has a Gross Margin of 53.20%. This is in the better half of the industry: MRX outperforms 60.83% of its industry peers.
  • In the last couple of years the Gross Margin of MRX has grown nicely.
Industry RankSector Rank
OM 5.89%
PM (TTM) 8.58%
GM 53.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-4.59%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MRX Health Analysis

2.1 Basic Checks

  • MRX has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MRX has been reduced compared to a year ago.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • MRX has an Altman-Z score of 0.32. This is a bad value and indicates that MRX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.32, MRX is doing worse than 66.25% of the companies in the same industry.
  • MRX has a debt to FCF ratio of 27.61. This is a negative value and a sign of low solvency as MRX would need 27.61 years to pay back of all of its debts.
  • MRX has a Debt to FCF ratio (27.61) which is in line with its industry peers.
  • MRX has a Debt/Equity ratio of 11.45. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 11.45, MRX is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF 27.61
Altman-Z 0.32
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.09, MRX perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
  • MRX has a Quick Ratio of 1.07. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.07, MRX perfoms like the industry average, outperforming 48.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.07
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MRX Growth Analysis

3.1 Past

  • MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.32%, which is quite impressive.
  • Measured over the past years, MRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 44.09% on average per year.
  • The Revenue has grown by 25.39% in the past year. This is a very strong growth!
  • MRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 54.67% yearly.
EPS 1Y (TTM)42.32%
EPS 3Y44.09%
EPS 5YN/A
EPS Q2Q%48.68%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y54.67%
Revenue growth 5YN/A
Sales Q2Q%37.66%

3.2 Future

  • MRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.51% yearly.
  • MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.06% yearly.
EPS Next Y18.42%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year22.27%
Revenue Next 2Y15.02%
Revenue Next 3Y14.06%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. MRX Valuation Analysis

4.1 Price/Earnings Ratio

  • MRX is valuated correctly with a Price/Earnings ratio of 12.82.
  • MRX's Price/Earnings ratio is in line with the industry average.
  • MRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.87.
  • With a Price/Forward Earnings ratio of 10.82, the valuation of MRX can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MRX indicates a somewhat cheap valuation: MRX is cheaper than 64.58% of the companies listed in the same industry.
  • MRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 12.82
Fwd PE 10.82
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MRX is valued cheaply inside the industry as 84.17% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA -53.43
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MRX's earnings are expected to grow with 14.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y14.51%
EPS Next 3Y14.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. MRX Dividend Analysis

5.1 Amount

  • MRX has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 6.64, MRX is paying slightly less dividend.
  • Compared to the average S&P500 Dividend Yield of 1.82, MRX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

  • MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • MRX pays out 18.85% of its income as dividend. This is a sustainable payout ratio.
DP18.85%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MRX Dividend Payout.MRX Dividend Payout, showing the Payout Ratio.MRX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MRX Fundamentals: All Metrics, Ratios and Statistics

MAREX GROUP PLC

NASDAQ:MRX (4/17/2026, 8:00:02 PM)

After market: 51.6779 +0.16 (+0.31%)

51.52

+0.06 (+0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-03
Earnings (Next)05-13
Inst Owners74.27%
Inst Owner Change0%
Ins Owners5.57%
Ins Owner Change-0.43%
Market Cap3.76B
Revenue(TTM)3.43B
Net Income(TTM)294.40M
Analysts80
Price Target55.52 (7.76%)
Short Float %5.12%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend0.72
Dividend Growth(5Y)N/A
DP18.85%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-16
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.03%
Min EPS beat(2)2.66%
Max EPS beat(2)9.4%
EPS beat(4)3
Avg EPS beat(4)5.43%
Min EPS beat(4)-0.13%
Max EPS beat(4)9.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.94%
Min Revenue beat(2)0.61%
Max Revenue beat(2)11.26%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)0.61%
Max Revenue beat(4)11.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.13%
PT rev (3m)11.73%
EPS NQ rev (1m)27.36%
EPS NQ rev (3m)26.82%
EPS NY rev (1m)10.91%
EPS NY rev (3m)10.32%
Revenue NQ rev (1m)19.31%
Revenue NQ rev (3m)28.51%
Revenue NY rev (1m)10.05%
Revenue NY rev (3m)10.46%
Valuation
Industry RankSector Rank
PE 12.82
Fwd PE 10.82
P/S 1.1
P/FCF 5.8
P/OCF 5.63
P/B 2.97
P/tB 4.05
EV/EBITDA -53.43
EPS(TTM)4.02
EY7.8%
EPS(NY)4.76
Fwd EY9.24%
FCF(TTM)8.88
FCFY17.24%
OCF(TTM)9.15
OCFY17.76%
SpS47.04
BVpS17.33
TBVpS12.73
PEG (NY)0.7
PEG (5Y)N/A
Graham Number39.5877 (-23.16%)
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 23.29%
ROCE 5.44%
ROIC 0.95%
ROICexc 4.71%
ROICexgc 5.27%
OM 5.89%
PM (TTM) 8.58%
GM 53.2%
FCFM 18.88%
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)1.87%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.79%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-4.59%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF 27.61
Debt/EBITDA 60.77
Cap/Depr 54.85%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 280.23%
Profit Quality 220.01%
Current Ratio 1.09
Quick Ratio 1.07
Altman-Z 0.32
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.73%
Cap/Depr(5y)63.64%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.72%
Profit Quality(3y)447.82%
Profit Quality(5y)479.97%
High Growth Momentum
Growth
EPS 1Y (TTM)42.32%
EPS 3Y44.09%
EPS 5YN/A
EPS Q2Q%48.68%
EPS Next Y18.42%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)25.39%
Revenue growth 3Y54.67%
Revenue growth 5YN/A
Sales Q2Q%37.66%
Revenue Next Year22.27%
Revenue Next 2Y15.02%
Revenue Next 3Y14.06%
Revenue Next 5YN/A
EBIT growth 1Y38.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.46%
EBIT Next 3Y17.14%
EBIT Next 5YN/A
FCF growth 1Y-43.36%
FCF growth 3Y44.16%
FCF growth 5YN/A
OCF growth 1Y-42.63%
OCF growth 3Y43.56%
OCF growth 5YN/A

MAREX GROUP PLC / MRX Fundamental Analysis FAQ

What is the fundamental rating for MRX stock?

ChartMill assigns a fundamental rating of 4 / 10 to MRX.


What is the valuation status for MRX stock?

ChartMill assigns a valuation rating of 6 / 10 to MAREX GROUP PLC (MRX). This can be considered as Fairly Valued.


What is the profitability of MRX stock?

MAREX GROUP PLC (MRX) has a profitability rating of 4 / 10.


What are the PE and PB ratios of MAREX GROUP PLC (MRX) stock?

The Price/Earnings (PE) ratio for MAREX GROUP PLC (MRX) is 12.82 and the Price/Book (PB) ratio is 2.97.


Can you provide the financial health for MRX stock?

The financial health rating of MAREX GROUP PLC (MRX) is 2 / 10.